| Patient | Liliʻuokalani |
|---|---|
| Date of birth | 1838-09-02 |
| Identifiers | MRN HR-ET024-SYN-TD; SSN (made up) 000-24-3086 |
| Document date | 1917-03-17 |
| Author | Kealani Morrison-Takeda, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Stroke clinic the morning after the emergency evaluation. [S]
Liliʻuokalani is seen the morning after her emergency evaluation, with two members of her ʻohana whom she asked to come, and is seen the same day by Dr. Abernethy-Sato of vascular neurology. The episode two days ago, about 20 minutes of right hand weakness and difficulty finding words while she was playing the piano, has not recurred. In the emergency department yesterday the CT showed no bleeding, the CT angiogram showed no blocked vessel and a calcified plaque narrowing the left internal carotid artery by less than 50%, and she passed the bedside swallow screen; she was given aspirin 325 mg and clopidogrel 300 mg about 18 hours after the symptoms began and went home. This morning's MRI shows a small new infarct in the left precentral cortex, so the episode was a minor stroke, not a transient ischemic attack. The echocardiogram shows normal pumping, a mildly enlarged left atrium and no clot. She has had no palpitations. She asks plainly what has happened, and wants her ʻohana to understand it too. [S]
| Element | Detail |
|---|---|
| Emergency evaluation | CT: no hemorrhage. CT angiography: no occlusion; left internal carotid plaque under 50%. Swallow screen passed |
| MRI | 8 mm acute infarct, left precentral cortex |
| Echocardiogram | Ejection fraction 60%; left atrium mildly enlarged; no thrombus |
| Antiplatelets | Aspirin and clopidogrel loaded about 18 hours after onset |
| Cognition | MoCA 26 |
| System | Result | Finding |
|---|---|---|
| Neurological | Negative | No new weakness, numbness, speech, vision or balance problem since the episode |
| Cardiovascular | Negative | No palpitations, chest pain or fainting |
| Hematologic | Negative | No bruising or bleeding on two antiplatelets |
| Psychiatric | Positive | Worried about another episode; PHQ-2 score 1 |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Aspirin 81 mg delayed-release oral tablet, one tablet daily for 21 days, after a 325 mg loading dose in the emergency department | One tablet daily for 21 days | Oral route | 1917-03-16 to 1917-04-06 | completed | S |
| Clopidogrel 75 mg oral tablet, one tablet daily, after a 300 mg loading dose in the emergency department | One tablet daily | Oral route | 1917-03-16 to 1917-04-20 | completed | S |
| Atorvastatin 40 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1917-03-16 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1917-03-17 | Body height | 160 | cm | S |
| 1917-03-17 | Body weight | 58 | kg | S |
| 1917-03-17 | Body mass index (BMI) [Ratio] | 22.7 | kg/m2 | S |
| 1917-03-17 | Systolic blood pressure | 148 | mm[Hg] | S |
| 1917-03-17 | Diastolic blood pressure | 86 | mm[Hg] | S |
| 1917-03-17 | Heart rate | 70 | /min | S |
| 1917-03-17 | Respiratory rate | 16 | /min | S |
| 1917-03-17 | Body temperature | 36.7 | Cel | S |
| 1917-03-17 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1917-03-17 | Total score [NIH Stroke Scale] | 0 | {score} | S | ||
| 1917-03-17 | Left ventricular Ejection fraction | 60 | % | 50-70% | Normal | S |
| 1917-03-17 | Left atrial End-systolic volume (by US.2D+Calculated by biplane method of disks)/Body surface area | 37 | mL/m2 | <=34 mL/m² | High | S |
| 1917-03-17 | Total score [MoCA] | 26 | {score} | S | ||
| 1917-03-17 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S |
Vital signs recorded on 1917-03-17; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Alert and composed; blood pressure 148/86, pulse 70 and regular |
| Neurological | NIH Stroke Scale 0; speech fluent with normal naming and repetition; no drift; normal grip and rapid finger movements of both hands; normal gait |
| Neck | No carotid bruit |
| Cardiovascular | Regular rhythm; no murmur |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Transient weakness and clumsiness of the right hand with word-finding difficulty, lasting about 20 minutes and fully resolved, the afternoon before the visit; suspected transient ischemic attack, ABCD2 score 5 (high risk); NIH Stroke Scale 0 | resolved | provisional | G45.9 | S — Synthetic presenting problem; resolved into the stroke diagnosis when diffusion MRI showed a small infarct at the stroke clinic the next day. Not a claim about her real symptoms. |
| Minor ischemic stroke: a small acute infarct in the cortex of the left precentral gyrus (left middle cerebral artery territory) on diffusion MRI, embolic in pattern, with full recovery (NIH Stroke Scale 0); source found to be paroxysmal atrial fibrillation; synthetic modern episode linked to her documented death from a stroke | active | confirmed | I63.412 | S — Synthetic modern diagnosis made at the stroke clinic the day after the visit; the 1917 cause of death remains D. |
| Hypertension: told of borderline readings in past years and not treated; 156/88 mmHg at intake | active | confirmed | I10 | S — Synthetic risk factor; no blood pressure from her lifetime is recorded in the cited sources. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure in the clinic and at home (target below 130/80 mmHg) and weight | Every visit | Completed today | 148/86 mmHg; 58.0 kg; home monitor provided |
| Medication safety | Antithrombotic therapy and adherence | Every visit | Completed today | Day 2 of 21 days of aspirin and clopidogrel; no bleeding |
| Examination | Neurological status (NIH Stroke Scale at the event; modified Rankin Scale at 90 days) and new symptoms | At the event and with any change; modified Rankin Scale at 90 days | Completed today | NIH Stroke Scale 0 in the emergency department and today |
| Imaging | Brain MRI with diffusion | At the event | Completed today | 8 mm acute infarct in the left precentral cortex |
| Imaging | Carotid and intracranial vessel imaging | At the event; follow-up only for treated or moderate or greater stenosis | Completed today | CT angiography in the emergency department: left internal carotid plaque under 50%; no intracranial stenosis |
| Imaging | Echocardiogram | At the event | Completed today | Ejection fraction 60%; left atrial volume index 37 mL/m2; no thrombus |
| Imaging | ECG and prolonged rhythm monitoring for atrial fibrillation | ECG at baseline; at least 30 days of monitoring within six months of the event | Ordered | ECG at intake: sinus rhythm. 30-day patch monitor applied today |
| Laboratory | Lipid panel (LDL goal below 70 mg/dL) | Four to twelve weeks after starting a statin, then every three to twelve months | Ordered | LDL 132 mg/dL at intake; atorvastatin 40 mg started; panel due in four to twelve weeks |
| Laboratory | Diabetes screen (hemoglobin A1c) | At the event, then periodically | Up to date | 5.5% at intake |
| Survey | Cognitive screen (MoCA) | After the event, again within the first year, then periodically | Completed today | MoCA 26 |
| Survey | Depression screen (PHQ-2, PHQ-9) | At the first post-stroke visit, then at least yearly | Completed today | PHQ-2 1; PHQ-9 planned at the three-month review |
| Examination | Swallow screen | Before any food or drink after a stroke | Up to date | Bedside swallow screen passed in the emergency department; eating normally |
| Examination | Falls risk | Every visit | Completed today | No falls; steady gait |
| Self-management | Tobacco, alcohol and physical activity | Every visit | Completed today | Never smoker; alcohol rarely; walks daily |
| Self-management | BE FAST and calling 911 | Every visit | Completed today | Taught to her and two members of her ʻohana |
| Self-management | Culturally safe care: her choices, ʻohana involvement and Native Hawaiian healing alongside clinic care | Every visit | Completed today | She leads the decisions with her ʻohana present; lomilomi and hoʻoponopono offered alongside clinic care; nothing further asked |
| Referral | Vascular neurology consultation | At the event | Completed today | Seen by Dr. Abernethy-Sato today |
Goal progress:
Guideline basis: 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association (2021); Primary Care of Adult Patients After Stroke: A Scientific Statement From the American Heart Association/American Stroke Association (2021); Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) (2018); Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) (2013); 2024 ACC Expert Consensus Decision Pathway on Practical Approaches for Arrhythmia Monitoring After Stroke (2024); CMID: Clinical Monitoring Intelligence Database, stroke and transient ischemic attack, atrial fibrillation and hypertension monographs (2026); Signs and Symptoms of Stroke (2026); Ke Ola Mamo: a Native Hawaiian Health Care System serving Oʻahu (medical care, lomilomi and community health workers) (2026)
Follow-up: Five-week review when the monitor result is ready. Call 911 for any BE FAST sign, even if it passes. Call for bleeding or black stools. Next scheduled visit 1917-04-20: five-week review: rhythm monitor result, anticoagulation decision, lipids, kidney function and blood pressure. [S]